Gbenga Kazeem

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila et al. · The Lancet Infectious Diseases · 2017 · 208 citations · Full text

Patients 60, Antimicrobial Susceptibility, Antibiotics +7

Integrating Case-control and TDT Studies

Gbenga Kazeem, Martin Farrall · Annals of Human Genetics · 2005 · 153 citations

Empirical Case Study, Polygenic Risk, Genetic Epidemiology +19

Integrating Case‐control and TDT Studies

Gbenga Kazeem, Martin Farrall · Annals of Human Genetics · 2005 · 138 citations

Empirical Case Study, Genetic Epidemiology, Population Health Sciences +24

High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients

Gbenga Kazeem, Charles Cox, Jennifer L. Aponte et al. · Pharmacogenetics and Genomics · 2009 · 109 citations

Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations

Nathalie Vionnet, David‐Alexandre Trégouët, Gbenga Kazeem et al. · Diabetes · 2006 · 78 citations · Full text

Genetics, Plausible Candidate Genes, Genetic Epidemiology +18